Analyst Ratings February 13, 2026

Barclays Lowers H&M Rating to Underweight, Flags Valuation and Weakening Sales

Bank cuts stance on Hennes & Mauritz and sets SEK162 price target amid subdued sales and mixed operational gains

By Maya Rios
Barclays Lowers H&M Rating to Underweight, Flags Valuation and Weakening Sales

Barclays has moved Hennes & Mauritz AB (H&M) from Equalweight to Underweight and set a SEK162 price target, citing limited signs of a consumer rebound for the brand and a valuation that looks rich versus peers. While H&M has trimmed costs, improved margins and reduced inventory, Barclays says evidence is lacking that sales will recover, and it views an earnings re-rating predicated on stronger sales as unlikely. Recent company actions include a one billion SEK share buyback and a stronger-than-expected fourth-quarter 2025 EBIT, though JPMorgan continues to carry an Underweight rating.

Key Points

  • Barclays downgraded Hennes & Mauritz AB from Equalweight to Underweight and set a SEK162 price target, implying about 14% downside.
  • The bank notes modest sales growth through 2024 and 2025 relative to peers and a decline in sales in early 2026, despite operational improvements such as lower costs, margin recovery and tighter inventory.
  • H&M announced a SEK1 billion buyback program approved at its 2025 AGM and reported Q4 2025 EBIT that beat estimates by 13%; JPMorgan retains an Underweight rating due to ongoing cost pressures.

Barclays has downgraded Hennes & Mauritz AB from Equalweight to Underweight and assigned a price objective of SEK162.00, which the bank says implies roughly 14% downside from current levels.

The investment bank's decision reflects what it describes as a lack of convincing evidence that the H&M brand is regaining consumer momentum. Barclays' note highlights that sales growth at H&M remained muted through 2024 and 2025 when compared with peers, and that sales turned negative in early 2026.

At the same time, Barclays acknowledged operational improvements at the Swedish retailer. The bank pointed to a leaner cost base, a recovery in gross margins and a tighter inventory position as positive developments. However, it said those improvements do not, in its view, demonstrate that the brand has started to win back shoppers in a way that would support sustained sales expansion.

Valuation was another central concern for Barclays. The bank highlighted H&M's calendar year 2027 price-to-earnings multiple of 21x and compared it with several peers: NEXT at 15.5x, Marks & Spencer at 11.5x and Zalando at 11x, while Inditex sits higher at 24x. Barclays suggested the recent upward re-rating of H&M's shares has been driven chiefly by an improved margin outlook, but warned that the market is pricing-in sales-led earnings upgrades that the bank judges unlikely to occur.

Other corporate developments were noted alongside Barclays' action. H&M reported a stronger-than-expected result in its fourth quarter of 2025, with earnings before interest and taxes exceeding forecasts by 13%. Despite that beat, JPMorgan has kept an Underweight recommendation on the stock, citing persistent cost pressures.

Separately, shareholders at H&M's 2025 annual general meeting approved a SEK1 billion share buyback program. The company said the repurchase will target its class B shares as a means of returning capital to investors and adjusting the capital structure. These measures illustrate management's efforts to manage financial policy while the company navigates the current market challenges.


Bottom line - Barclays has downgraded H&M to Underweight with a SEK162 price target, pointing to subdued sales trends and a valuation that, in its view, relies on sales improvements that may not materialize despite operational gains and recent shareholder returns.

Risks

  • Continued weak sales - If consumer traction for the H&M brand does not improve, earnings may remain constrained, affecting retail and consumer discretionary sectors.
  • Valuation mismatch - H&M's 2027 P/E of 21x is higher than several peers, creating the risk that market expectations for sales-driven upgrades may not be met, impacting equity investors and market valuations.
  • Persistent cost pressures - Ongoing cost challenges cited by JPMorgan could limit the impact of margin improvements and buybacks on shareholder returns, affecting corporate finance and capital allocation strategies.

More from Analyst Ratings

HSBC Lowers Synopsys Rating to Hold, Flags 2026 as Transition Year Feb 21, 2026 DA Davidson Cuts Uber Price Target Citing Elevated Investment; Buy Rating Intact Feb 20, 2026 Freedom Capital Markets Raises Freeport-McMoRan to Buy, Cites Copper Supply Tightness Feb 20, 2026 BofA Lifts CF Industries Price Target After Strong Q4 EBITDA; Maintains Underperform Rating Feb 20, 2026 Truist Lifts Tandem Diabetes Price Target as Company Shifts Toward Pharmacy Model Feb 20, 2026